Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2015 | Carpal tunnel syndrome: US strain imaging for diagnosis | Liao Y.-Y.; Lee W.-N.; Lee M.-R.; WEN-SHIANG CHEN ; Chiou H.-J.; Kuo T.-T.; Yeh C.-K. | Radiology | 33 | 30 | |
2021 | Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma | Cheng W.-C.; Chang C.-Y.; Lo C.-C.; Hsieh C.-Y.; Kuo T.-T.; Tseng G.-C.; Wong S.-C.; Chiang S.-F.; Huang K.C.-Y.; Liang-Chuan Lai ; TZU-PIN LU ; Chao K.S.C.; Sher Y.-P. | Theranostics | 24 | 21 | |
2014 | Introduction | SHOU-DE LIN ; Ku L.-W; Cambria E; Kuo T.-T. | SocialNLP 2014 - 2nd Workshop on Natural Language Processing for Social Media, in conjunction with COLING 2014 | 0 | ||
2017 | Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians | Chen C.-B.; Hsiao Y.-H.; Wu T.; Hsih M.-S.; Tassaneeyakul W.; Jorns T.P.; Sukasem C.; Hsu C.-N.; Su S.-C.; Chang W.-C.; Hui R.C.-Y.; CHIA-YU CHU ; Chen Y.-J.; Wu C.-Y.; Hsu C.-K.; Chiu T.-M.; Sun P.-L.; Lee H.-E.; Yang C.-Y.; Kao P.-H.; Yang C.-H.; Ho H.-C.; Lin J.-Y.; Chang Y.-C.; Chen M.-J.; Lu C.-W.; Ng C.Y.; Kuo K.-L.; Lin C.-Y.; Yang C.-S.; Chen D.-P.; Chang P.-Y.; Wu T.-L.; Lin Y.-J.; Weng Y.-C.; Kuo T.-T.; Hung S.-I.; Chung W.-H.; For the Taiwan Severe Cutaneous Adverse Reaction Consortium | Neurology | 104 | 90 | |
2020 | Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression | Lin C.-C.; Huang Y.-K.; Cho C.-F.; Lin Y.-S.; Lo C.-C.; Kuo T.-T.; Tseng G.-C.; Cheng W.-C.; Chang W.-C.; Hsiao T.-H.; Liang-Chuan Lai ; JIN-YUAN SHIH ; Liu Y.-H.; Clifford Chao K.S.; Hsu J.L.; Lee P.-C.; Sun X.; Hung M.-C.; Sher Y.-P. | Theranostics | 19 | 15 | |
2023 | ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions | Juan Y.-C.; Su Y.-F.; Bai C.-H.; Fan Y.-C.; Kuo T.-T.; HUI-HSIN KO ; Peng H.-H.; CHUN-PIN CHIANG ; Fwu C.-W.; SHIH-JUNG CHENG | Oral Diseases | 5 | 7 |